Purchases and Sales Made in Q4 2022 in Alnylam Pharmaceuticals, Inc. (ALNY)
This table provides information about the institutional ownership of Alnylam Pharmaceuticals, Inc. (ALNY) during Q4 2022. The information is specifically focused on institutions that hold shares of ALNYLAM PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-35.5K- 3.72% |
$6.6M - $8.58M
|
921K
$217M
|
|
|
Feb 14, 2023
Q4 2022
|
Holocene Advisors, LP
New York, NY |
SELL
|
- |
-44.7K- 6.95% |
$8.3M - $10.8M
|
599K
$141M
|
|
|
Feb 13, 2023
Q4 2022
|
Uss Investment Management LTD
|
SELL
|
- |
-45.6K- 59.33% |
$8.45M - $11M
|
31.2K
$7.37M
|
|
|
Feb 14, 2023
Q4 2022
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-47.3K- 98.91% |
$8.77M - $11.4M
|
519
$122K
|
|
|
Feb 14, 2023
Q4 2022
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-59.6K- 99.18% |
$11.1M - $14.4M
|
490
$116K
|
|
|
Feb 13, 2023
Q4 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-68K- 9.21% |
$12.6M - $16.4M
|
670K
$158M
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-72.5K- 15.59% |
$13.5M - $17.5M
|
393K
$92.7M
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-72.5K- 15.59% |
$13.5M - $17.5M
|
393K
$92.7M
|
|
|
Feb 09, 2023
Q4 2022
|
First Trust Advisors LP
Wheaton, IL |
SELL
|
- |
-74.4K- 15.03% |
$13.8M - $17.9M
|
421K
$99.2M
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-81.1K- 98.26% |
$15.1M - $19.6M
|
1.44K
$340K
|
|
|
Feb 14, 2023
Q4 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-89.3K- 86.9% |
$16.6M - $21.6M
|
13.5K
$3.18M
|
|
|
Jan 24, 2023
Q4 2022
|
Baillie Gifford & CO
|
SELL
|
- |
-107K- 1.12% |
$19.8M - $25.8M
|
9.41M
$2.22B
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-108K- 7.21% |
$20.1M - $26.1M
|
1.39M
$328M
|
|
|
Feb 14, 2023
Q4 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-109K- 18.99% |
$20.2M - $26.3M
|
465K
$110M
|
|
|
Feb 14, 2023
Q4 2022
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-154K- 56.42% |
$28.6M - $37.2M
|
119K
$28.1M
|
|
|
Jun 20, 2024
Q4 2022
|
Abrdn PLC
|
SELL
|
- |
-206K- 94.01% |
$38.2M - $49.7M
|
13.1K
$3.1M
|
|
|
Feb 13, 2023
Q4 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-234K- 34.66% |
$43.5M - $56.5M
|
442K
$104M
|
|
|
Feb 14, 2023
Q4 2022
|
Casdin Capital, LLC
New York, NY |
SELL
|
- |
-283K- 43.67% |
$52.5M - $68.3M
|
365K
$86.1M
|
|
|
Feb 14, 2023
Q4 2022
|
Farallon Capital Management LLC
San Francisco, CA |
SELL
|
- |
-298K- 69.65% |
$55.4M - $72M
|
130K
$30.7M
|
|
|
Feb 14, 2023
Q4 2022
|
Dodge & Cox
San Francisco, CA |
SELL
|
- |
-299K- 6.11% |
$55.4M - $72M
|
4.59M
$1.08B
|
|
|
Feb 13, 2023
Q4 2022
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-496K- 59.09% |
$92M - $120M
|
343K
$81M
|
|
|
Feb 14, 2023
Q4 2022
|
Amundi
Paris, I0 |
SELL
|
- |
-528K- 44.18% |
$98M - $128M
|
668K
$158M
|
|
|
Aug 11, 2023
Q4 2022
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-567K- 62.31% |
$105M - $137M
|
343K
$81M
|
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-16M- 96.27% |
$2.96B - $3.85B
|
619K
$146M
|